These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17295832)

  • 1. Prostate cancer following testosterone replacement in Klinefelter syndrome.
    Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
    ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic complications of testosterone replacement therapy.
    Jackson JA; Waxman J; Spiekerman AM
    Arch Intern Med; 1989 Oct; 149(10):2365-6. PubMed ID: 2679476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer in a hypogonadal male receiving androgen supplementation.
    Ferri M; Norman RW
    Can J Urol; 2000 Jun; 7(3):1055-6. PubMed ID: 11118282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].
    Morgunov LIu; Vertkin AL; Pushkar' DIu
    Urologiia; 2007; (5):49-51. PubMed ID: 18254226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.
    Hwang JJ; Dharmawardana PG; Uchio EM; Wynberg J; Phillips JL
    Urology; 2003 Nov; 62(5):941. PubMed ID: 14624928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
    Ebert T; Jockenhövel F; Morales A; Shabsigh R
    Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deficiency in the etiology and treatment of erectile dysfunction.
    Gore JL; Swerdloff RS; Rajfer J
    Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome.
    Selice R; Caretta N; Di Mambro A; Torino M; Palego P; Ferlin A; Foresta C
    Eur J Endocrinol; 2013 Dec; 169(6):743-9. PubMed ID: 24001894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M; Lipshultz LI
    Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone replacement therapy on serum PSA in patients with Klinefelter syndrome.
    Shibasaki T; Sasagawa I; Suzuki Y; Yazawa H; Ichiyanagi O; Matsuki S; Miura M; Nakada T
    Arch Androl; 2001; 47(3):173-6. PubMed ID: 11695839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone and erectile physiology.
    Guay AT
    Aging Male; 2006 Dec; 9(4):201-6. PubMed ID: 17178555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
    Halland A; Jønler M; Pedersen KV
    Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between hypogonadism and erectile dysfunction.
    Hwang TI; Lin YC
    Int J Impot Res; 2008; 20(3):231-5. PubMed ID: 18305486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome.
    McLaren D; Siemens DR; Izard J; Black A; Morales A
    BJU Int; 2008 Nov; 102(9):1142-6. PubMed ID: 18540933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?
    Landau D; Tsakok T; Aylwin S; Hughes S
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
    Morales A; Black AM; Emerson LE
    BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.